Literature DB >> 30283272

Extended Donor Typing by Pooled Capillary Electrophoresis: Impact in a Routine Setting.

Franz F Wagner1, Andrea Doescher2, Rita Bittner1, Thomas H Müller1.   

Abstract

BACKGROUND: PCR with sequence-specific priming using allele-specific fluorescent primers and analysis on a capillary sequencer is a standard technique for DNA typing. We aimed to adapt this method for donor typing in a medium-throughput setting.
METHODS: Using the Extract-N-Amp PCR system, we devised a set of eight multiplex allele-specific PCR with fluorescent primers for Fya/Fyb, Jka/Jkb, M/N, and S/s. The alleles of a gene were discriminated by the fluorescent color; donor and polymorphism investigated were encoded by product length. Time, cost, and routine performance were collated. Discrepant samples were investigated by sequencing. The association of new alleles with the phenotype was evaluated by a step-wise statistical analysis.
RESULTS: On validation using 312 samples, for 1.1% of antigens (in 5.4% of samples) no prediction was obtained. 99.96% of predictions were correct. Consumable cost per donor were below EUR 2.00. In routine use, 92.2% of samples were successfully predicted. Discrepancies were most frequently due to technical reasons. A total of 11 previously unknown alleles were detected in the Kell, Lutheran, and Colton blood group systems. In 2017, more than 20% of the RBC units prepared by our institution were from donors with predicted antigen status. A steady supply of Yt(a-), Co(a-) and Lu(b-) RBC units was ensured.
CONCLUSIONS: Pooled capillary electrophoresis offers a suitable alternative to other methods for extended donor DNA typing. Establishing a large cohort of typed donors improved transfusion support for patients.

Entities:  

Keywords:  Blood donor typing; Colton blood group; Immunohematology; Kell blood group; Lutheran blood group; Molecular blood group typing; Null allele

Year:  2018        PMID: 30283272      PMCID: PMC6158588          DOI: 10.1159/000490155

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  25 in total

1.  Single PCR multiplex SNaPshot reaction for detection of eleven blood group nucleotide polymorphisms: optimization, validation, and one year of routine clinical use.

Authors:  Julie Di Cristofaro; Monique Silvy; Jacques Chiaroni; Pascal Bailly
Journal:  J Mol Diagn       Date:  2010-04-29       Impact factor: 5.568

2.  Set-up and routine use of a database of 10,555 genotyped blood donors to facilitate the screening of compatible blood components for alloimmunized patients.

Authors:  J Perreault; J Lavoie; P Painchaud; M Côté; J Constanzo-Yanez; R Côté; G Delage; F Gendron; S Dubuc; B Caron; R Lemieux; M St-Louis
Journal:  Vox Sang       Date:  2009-03-16       Impact factor: 2.144

3.  DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.

Authors:  K R Ribeiro; M H Guarnieri; D C da Costa; F F Costa; J Pellegrino; L Castilho
Journal:  Vox Sang       Date:  2009-04-08       Impact factor: 2.144

4.  Donors with a rare pheno (geno) type.

Authors:  H W Reesink; C P Engelfriet; H Schennach; C Gassner; S Wendel; R Fontão-Wendel; M A de Brito; P Sistonen; J Matilainen; T Peyrard; B N Pham; P Rouger; P Y Le Pennec; W A Flegel; I von Zabern; C K Lin; W C Tsoi; I Hoffer; K Barotine-Toth; S R Joshi; K Vasantha; V Yahalom; O Asher; C Levene; M A Villa; N Revelli; N Greppi; M Marconi; Y Tani; C C Folman; M de Haas; M M W Koopman; E Beckers; D S Gounder; P Flanagan; L Wall; E Aranburu Urtasun; H Hustinx; C Niederhauser; C Flickinger; S J Nance; G M Meny
Journal:  Vox Sang       Date:  2008-10       Impact factor: 2.144

5.  High-throughput molecular profiling of blood donors for minor red blood cell and platelet antigens.

Authors:  Alexandre Montpetit; Michael S Phillips; Ian Mongrain; Réal Lemieux; Maryse St-Louis
Journal:  Transfusion       Date:  2006-05       Impact factor: 3.157

6.  Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.

Authors:  Yanli Ji; Barbera Veldhuisen; Peter Ligthart; Lonneke Haer-Wigman; John Jongerius; Mohamed Boujnan; Aicha Ait Soussan; Guangping Luo; Yongshui Fu; C Ellen van der Schoot; Masja de Haas
Journal:  Transfusion       Date:  2014-08-25       Impact factor: 3.157

7.  Erythrogene: a database for in-depth analysis of the extensive variation in 36 blood group systems in the 1000 Genomes Project.

Authors:  Mattias Möller; Magnus Jöud; Jill R Storry; Martin L Olsson
Journal:  Blood Adv       Date:  2016-12-16

8.  Integration of red cell genotyping into the blood supply chain: a population-based study.

Authors:  Willy A Flegel; Jerome L Gottschall; Gregory A Denomme
Journal:  Lancet Haematol       Date:  2015-07       Impact factor: 18.959

9.  Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes.

Authors:  Franz F Wagner; Rita Bittner; Eduard K Petershofen; Andrea Doescher; Thomas H Müller
Journal:  Transfusion       Date:  2008-04-15       Impact factor: 3.157

10.  Disruption of SMIM1 causes the Vel- blood type.

Authors:  Bryan A Ballif; Virginie Helias; Thierry Peyrard; Cécile Menanteau; Carole Saison; Nicole Lucien; Sébastien Bourgouin; Maude Le Gall; Jean-Pierre Cartron; Lionel Arnaud
Journal:  EMBO Mol Med       Date:  2013-04-15       Impact factor: 12.137

View more
  2 in total

1.  Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens.

Authors:  Jan Portegys; Gabi Rink; Pia Bloos; Erwin A Scharberg; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2018-09-24       Impact factor: 3.747

2.  Molecular Blood Group Screening in Donors from Arabian Countries and Iran Using High-Throughput MALDI-TOF Mass Spectrometry and PCR-SSP.

Authors:  Brigitte Katharina Flesch; Vanessa Scherer; Burkhard Just; Andreas Opitz; Oswin Ochmann; Anne Janson; Monika Steitz; Thomas Zeiler
Journal:  Transfus Med Hemother       Date:  2020-01-22       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.